Indegene summit explores AI-powered commercialization, honors industry leaders

Indegene Limited announced details of its Digital Summit 2025, held on September 24, 2025, in Princeton, New Jersey. The summit, titled "Life Sciences Leaders Reimagine AI-Powered Commercialization," focused on the practical application of Generative AI (GenAI) in commercial operations under the theme "From Chaos to Clarity - and Better Decisions." Discussions covered topics such as data unification, agent-augmented workforces, evolving pharma regulations, and future customer engagement models.

A key highlight of the summit was "The Vital Awards," which honored life sciences professionals across four categories: Patient Impact, Community Impact, Organizational Impact, and Market Impact. Honorees included Sunil Verma (AstraZeneca) for Patient Impact, Nathan Bowmaker (AstraZeneca) and Catherine Galvin (Merck) for Organizational Impact, and Marion Dumas (Sanofi) for Market Impact. The awards were judged by a cross-disciplinary jury of senior leaders from various sectors of the life sciences ecosystem.

Manish Gupta, chairman and chief executive officer of Indegene, congratulated the honorees, acknowledging their contributions to advancing the industry. Indegene, a tech-native life sciences specialist, leverages over 25 years of experience to help biopharma companies with commercialization strategy and execution.